SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside
SVB Leerink initiated coverage on Nkarta Inc (NASDAQ:NKTX) with an Outperform rating and a price target of $30 (117% implied upside). The…
Read Why Mizuho Is Bullish On Kraft Heinz
Mizuho analyst John Baumgartner initiated coverage of Kraft Heinz Co (NASDAQ:KHC) with a Buy rating and a price target of $48, implying…
Oppenheimer Assumes Cellectar Biosciences at Outperform, Announces Price Target of $5.5
Oppenheimer analyst Jeff Jones assumes Cellectar Biosciences (NASDAQ:CLRB) with a Outperform rating and announces Price Target of $5.5.
Oppenheimer Assumes Evaxion Biotech at Outperform, Announces Price Target of $16
Oppenheimer analyst Jeff Jones assumes Evaxion Biotech (NASDAQ:EVAX) with a Outperform rating and announces Price Target of $16.
Oppenheimer Assumes Ionis Pharmaceuticals at Outperform, Announces Price Target of $59
Oppenheimer analyst Justin Kim assumes Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform rating and announces Price Target of $59.
Oppenheimer Assumes Sera Prognostics at Outperform, Announces Price Target of $17
Oppenheimer analyst Francois Brisebois assumes Sera Prognostics (NASDAQ:SERA) with a Outperform rating and announces Price Target of $17.
RBC Capital Initiates Coverage On Penumbra with Outperform Rating, Announces Price Target of $195
RBC Capital analyst Shagun Singh initiates coverage on Penumbra (NYSE:PEN) with a Outperform rating and announces Price Target of $195.
BMO Capital Initiates Coverage On MCAN Financial with Market Perform Rating, Announces Price Target of C$18
BMO Capital analyst Etienne Ricard initiates coverage on MCAN Financial (TSX:MKP) with a Market Perform rating and announces Price Target of C$18.
SVB Leerink Initiates Coverage On Nkarta with Outperform Rating, Announces Price Target of $30
SVB Leerink analyst Daina Graybosch initiates coverage on Nkarta (NASDAQ:NKTX) with a Outperform rating and announces Price Target of $30.
JP Morgan Initiates Coverage On Altus Power with Neutral Rating, Announces Price Target of $9
JP Morgan analyst Mark Strouse initiates coverage on Altus Power (NYSE:AMPS) with a Neutral rating and announces Price Target of $9.